{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:36:21Z","timestamp":1769020581879,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This double-blind, randomized, parallel, placebo-controlled investigation evaluated the effects of cross-linked polyelectrolyte (CLP) on serum potassium and measures of congestion in patients with heart failure (HF) and chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The primary endpoint was change in serum potassium over time. Exploratory endpoints included: weight, physician and patient assessment of exertional dyspnoea, effect on N-terminal pro brain natriuretic peptide (NT-proBNP) levels, New York Heart Association (NYHA) classification, 6 min walk test (6MWT), and quality of life by Kansas City Cardiomyopathy Questionnaire (KCCQ). Serum potassium was similar in CLP (n =59) and placebo (n =52) groups throughout the 8-week study. Weight loss was greater in the CLP than in the placebo group at Weeks 1 (P =0.014) and 2 (P =0.004), and this trend continued until the end of the study. After 8 weeks, by physician assessment, the percentage of patients experiencing marked or disabling dyspnoea tended to be lower in the CLP than in the placebo group (7.3% vs. 23.9%, P =0.128). Fewer patients in the CLP than in the placebo group had NT-proBNP levels &amp;gt;1000 pg\/mL at Week 4 (P =0.039) and Week 8 (P =0.065). The proportion of patients improving by at least one NYHA functional class over the study was higher in the CLP than in the placebo group (48.8% vs. 17.4%; P =0.002). Effects on 6MWT at Week 8 (p =0.072) and quality of life (overall KCCQ score) at Week 4 (p =0.005) and 8 (P =0.062) all favoured the CLP cohort. Four treatment-unrelated deaths occurred in the CLP group and none in the placebo group (P =0.056).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In advanced, symptomatic HF with CKD, CLP is associated with beneficial clinical effects without significant serum potassium changes.<\/jats:p>\n                    <jats:p>Trial registration: NCT01265524.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfs074","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T22:23:36Z","timestamp":1337639016000},"page":"922-930","source":"Crossref","is-referenced-by-count":14,"title":["A Double-Blind, Randomized, Parallel, Placebo-Controlled Study Examining the Effect of Cross-Linked Polyelectrolyte in Heart Failure Patients with Chronic Kidney Disease"],"prefix":"10.1093","volume":"14","author":[{"given":"Maria Rosa","family":"Costanzo","sequence":"first","affiliation":[{"name":"Midwest Heart Foundation, Edward Heart Hospital , PO Box 3226, Naperville, IL, 60566 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Thomas","family":"Heywood","sequence":"additional","affiliation":[{"name":"Scripps Clinic , La Jolla, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry M.","family":"Massie","sequence":"additional","affiliation":[{"name":"University of California, San Francisco and San Francisco VAMC , San Francisco, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Iwashita","sequence":"additional","affiliation":[{"name":"Sorbent Therapeutics, Inc. , Sunnyvale, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Henderson","sequence":"additional","affiliation":[{"name":"Sorbent Therapeutics, Inc. , Sunnyvale, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merab","family":"Mamatsashvili","sequence":"additional","affiliation":[{"name":"Adapti Angio-Cardiology Clinic , Tbilisi ,","place":["Georgia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamayak","family":"Sisakian","sequence":"additional","affiliation":[{"name":"Yerevan State Medical University , Yerevan ,","place":["Armenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamlet","family":"Hayrapetyan","sequence":"additional","affiliation":[{"name":"Erebouni Medical Center , Yerevan ,","place":["Armenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Sager","sequence":"additional","affiliation":[{"name":"Sager Consulting Experts, Inc. , San Francisco, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[{"name":"University Medical Center Groningen , Groningen ,","place":["the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Albrecht","sequence":"additional","affiliation":[{"name":"Sorbent Therapeutics, Inc. , Sunnyvale, CA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026011921173672500_ejhfhfs074-bib-0001","first-page":"1977","article-title":"Focused Update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"119","author":"Jessup","year":"2009","journal-title":"Circulation 2009"},{"key":"2026011921173672500_ejhfhfs074-bib-0002","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"2026011921173672500_ejhfhfs074-bib-0003","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0735-1097(03)00765-4","article-title":"Studies of left ventricular dysfunction. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD)","volume":"42","author":"Domanski","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-103-1-1","article-title":"Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis","volume":"103","author":"Francis","year":"1985","journal-title":"Ann Intern Med"},{"key":"2026011921173672500_ejhfhfs074-bib-0005","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal Syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0006","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cardfail.2007.03.011","article-title":"High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database","volume":"13","author":"Heywood","year":"2007","journal-title":"J Card Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0007","first-page":"F1269","article-title":"Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport","volume":"255","author":"Stanton","year":"1988","journal-title":"Am J Physiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0008","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/eurheartj\/ehq502","article-title":"Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial","volume":"32","author":"Pitt","year":"2011","journal-title":"Eur Heart J"},{"key":"2026011921173672500_ejhfhfs074-bib-0009","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.1993.03510140062030","article-title":"Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction","volume":"270","author":"Bittner","year":"1993","journal-title":"JAMA"},{"key":"2026011921173672500_ejhfhfs074-bib-0010","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1067\/mhj.2003.151","article-title":"Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure","volume":"145","author":"Teerlink","year":"2003","journal-title":"Am Heart J"},{"key":"2026011921173672500_ejhfhfs074-bib-0011","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ahj.2004.12.010","article-title":"Cardiovascular Outcomes Research Consortium. Monitoring clinical changes in patients with heart failure: a comparison of methods","volume":"150","author":"Spertus","year":"2005","journal-title":"Am Heart J"},{"key":"2026011921173672500_ejhfhfs074-bib-0012","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026011921173672500_ejhfhfs074-bib-0013","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026011921173672500_ejhfhfs074-bib-0014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011921173672500_ejhfhfs074-bib-0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00424-009-0781-9","article-title":"Colonic potassium handling","volume":"459","author":"Sorensen","year":"2010","journal-title":"Pflugers Arch"},{"key":"2026011921173672500_ejhfhfs074-bib-0016","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehr058","article-title":"To bind or not to bind: potassium-lowering drugs in heart failure","volume":"32","author":"van der Meer","year":"2011","journal-title":"Eur Heart J"},{"key":"2026011921173672500_ejhfhfs074-bib-0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.109.899526","article-title":"Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies","volume":"3","author":"Bowling","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0018","first-page":"482A","article-title":"RLY5016: a novel, non-absorbed, therapeutic polymer for serum potassium control","volume":"21","author":"Huang","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2026011921173672500_ejhfhfs074-bib-0019","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","article-title":"Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study","volume":"373","author":"Teerlink","year":"2009","journal-title":"Lancet"},{"key":"2026011921173672500_ejhfhfs074-bib-0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1 receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"20107","journal-title":"N Engl J Med"},{"key":"2026011921173672500_ejhfhfs074-bib-0021","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality. Marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0023","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","article-title":"Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD","volume":"16","author":"Costanzo","year":"2010","journal-title":"J Cardiac Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1751-7133.2008.00037.x","article-title":"Loop diuretics can cause clinical natriuretic failure: a prescription for volume expansion","volume":"15","author":"Ali","year":"2009","journal-title":"Congest Heart Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.0000052623.16194.80","article-title":"Hemodilution is common in patients with advanced heart failure","volume":"107","author":"Androne","year":"2003","journal-title":"Circulation"},{"key":"2026011921173672500_ejhfhfs074-bib-0026","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9149(01)01975-0","article-title":"Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy","volume":"88","author":"Shah","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0027","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the study group on advanced heart failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"2026011921173672500_ejhfhfs074-bib-0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000164149","article-title":"Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE Registry","volume":"13","author":"Peacock","year":"2009","journal-title":"Cardiology"},{"key":"2026011921173672500_ejhfhfs074-bib-0029","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011921173672500_ejhfhfs074-bib-0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs074","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs074","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1093\/eurjhf\/hfs074","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1093\/eurjhf\/hfs074","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/8\/922\/66442510\/eurjhf_14_8_922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/8\/922\/66442510\/eurjhf_14_8_922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:22:58Z","timestamp":1768875778000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/14\/8\/922\/8428925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfs074","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8]]},"published":{"date-parts":[[2012,8,1]]}}}